Fragile sites are classified as common or rare depending on their occurrence in the populations. While rare sites are mainly associated with inherited diseases, common sites have been involved in somatic rearrangements found in the chromosomes of cancer cells. Here we study a mouse locus containing the ionotropic glutamate receptor delta 2 (grid2) gene in which spontaneous chromosome rearrangements occur frequently, giving rise to mutant animals in inbred populations. We identify and clone common fragile sites overlapping the mouse grid2 gene and its human ortholog GRID2, lying respectively at bands 6C1 and 4q22 in a 7-Mb-long region of synteny. These results show a third example of orthologous common sites conserved at the molecular level, and reveal an unexpected link between an inherited disease and an aphidicolin-sensitive region. Recurrent deletions of subregions of band 4q22 have been previously described in human hepatocellular carcinomas. This 15-Mb-long region appears precisely centered on the site described here, which strongly suggests that it also plays a specific role in hepatic carcinogenesis.
Introduction
Fragile sites are chromosomal loci where breaks, constrictions or gaps (BCG) occur recurrently when cells are grown under stressing conditions (Sutherland and Baker, 2000) . More than 100 fragile sites have been described and classified into two groups according to their occurrence in the population. Rare fragile sites (RFS) result from the expansion of unstable micro-or minisatellites and are present in a few percent of the individuals of a population (Jones et al., 2000; Hsu and Wang, 2002) . In contrast, common sites (CFS) are expressed in all individuals, and appear to be constitutive elements of mammalian chromosomes (Smith et al., 1998) . Aphidicolin (AP), an inhibitor of DNA polymerases a, d and e, is the archetype of CFS-inducing drugs (Glover et al., 1984) . Presently, the only sequence properties common to these sites are a high AT content and the presence of clusters of peaks of enhanced flexibility (Mishmar et al., 1998; Arlt et al., 2003) .
The contribution of RFS and CFS to genome rearrangements and diseases has long been studied but is still unclear. Some of the RFS, that is, FRAXA (fragile X syndrome), FRAXE and FRA11B (Jacobsen syndrome), have been associated with heritable genetic diseases, especially mental retardation (Smith et al., 1998; Jones et al., 2000) . In contrast, CFS have been proposed to play a role in the development of cancer (Yunis and Soreng, 1984) . Until recently, this was mostly inferred from cytogenetic correlation between their locations and those of cancer-associated chromosome rearrangements, and from the ability of a variety of carcinogenic drugs to induce CFS. More recently, hypoxia, a tumor microenvironment-dependent stress, was also shown to induce CFS (Coquelle et al., 1998) . It was further demonstrated that the human FHIT gene and its murine ortholog fhit, which respectively lie within FRA3B and Fra14A2, are often deleted or abnormally transcribed in various primary carcinomas (Smith et al., 1998; Huebner and Croce, 2001; Ginestier et al., 2003) . The demonstration that fhit behaves as a tumor suppressor gene again reinforced the hypothesis (Fong et al., 2000; Ginestier et al., 2003) . Deletions were also frequently found in the vicinity of other CFS, which suggests that their expression also inactivates tumor suppressor genes and drives the development of cancers (Arlt et al., 2003) . Cancer progression relies also on oncogene amplification (Brison, 1993) . Strikingly, it was shown that CFS activation drives the cycles of breakage-fusion-bridge, a mechanism responsible for accumulation of intrachromosomal amplicons in drug-resistant mutant cells (Coquelle et al., 1997) . More recent works identified human FRA7I and FRA7G at one boundary of the amplicons found in two tumor cell lines (Ciullo et al., 2002; Hellman et al., 2002) . Finally, breaks at CFS were also involved in the generation of secondary rearrangements formed at late stages of the amplifica-tion process (Coquelle et al., 1998 (Coquelle et al., , 2002 . Altogether, these studies link chromosome rearrangements that drive tumor progression to CFS activation.
Whether CFS are also involved in the generation of mutations responsible for inherited disease is still poorly documented. Here we studied an intriguing region of the mouse genome that contains the ionotropic glutamate receptor delta 2 (grid2) gene, which was shown to be allelic to hotfoot (Lalouette et al., 1998) . A high frequency of mutant animals presenting an ataxic phenotype arose spontaneously in different genetic backgrounds. Since the first hotfoot allele described in 1960, at least 16 new alleles have been reported in the mouse genome database (MGD, http://www.informatics.jacks.org). The existence of this genetic instability in grid2 made it of special interest to study this region with regard to the potential presence of a fragile site. By studying AP-treated mouse cells, we establish that a CFS does overlap grid2. GRID2, its human ortholog, was cloned by sequence homology with the mouse gene and mapped at 4q22 (Hu et al., 1998) . Here we show that the GRID2 gene also lies within a CFS, the location of which accounts well for the initiation of deletions recurrently found in hepatocellular carcinomas (HCC) (Bluteau et al., 2002) . We also show that the organization of the two sites, called Fra6C1 and FRA4F, is well conserved in the two genomes, especially the localization of subregions in which BCG occur more frequently.
Results

A fragile site overlaps the grid2 locus in the mouse genome
In order to determine whether a CFS is present at the grid2 locus, we analysed AP-treated mouse cells of the fibroblastic line 531. In contrast to cells of lines 3T3, 3T6 or CL1D that failed to efficiently enter mitosis with damaged DNA, metaphase spreads with broken chromosomes were readily observed in cells 531. Since the grid2 gene has been assigned to band 6C1, we first determined the status of chromosomes 6 in these cells (Figure 1a ). Metaphase spreads of untreated cells were hybridized with a painting probe specific to chromosome 6 and BAC 513J1, located as shown in Figure 2 . As exemplified in Figure 1a , we found three copies of chromosome 6 per cell. Two of them seem normal while the third one is involved in a Robertsonian fusion with an unidentified partner. At least at the cytogenetic level, this fusion did not further alter the structure of chromosome 6. Hence, line 531 appears well adapted to analyse the fragility of the grid2 locus.
Spreads of AP-treated cells were hybridized with a series of bacterial artificial chromosome (BAC) delimiting an 11.2 Mb-region overlapping the gene (Figure 2) . We confirmed the localization of grid2 at 6C1 (Figure 1b top, control panel) and showed that about 30% of the BCG observed on chromosome 6 occur in close proximity or within the fluorescent in situ hybridization (FISH) signals obtained with these BAC (Figure 1b top), both on normal and fused chromosomes. Ongoing recombination events involving this region were also repeatedly detected (Figure 1b , bottom). Altogether, BCG targeted to 6C1 represent some 4% of the total number of events observed within the whole genome.
We then determined the position of BCG relative to the FISH signal of each BAC ( Figure 1b , Table 1 ). From BAC 474E7 to BAC 101M21, the percentage of BCG distal to the signal decreases regularly from approximately 100 to 60%. Hybridization with BAC 101M21, 299A14 and 316M9 identifies an about 2.4-Mb-long region in which BCG distal to the FISH signal take place at relatively similar frequencies, which indicates that, although constituting the core of the site, this sequence is not particularly prone to BCG. The percentage of BCG distal to the signal of BAC 513J1 decreases to 33%, showing that breaks occur frequently in the region delimited by BAC316M9 and BAC 513J1, which contains the 3 0 end of the grid2 gene. The high number of BCG scored with BAC 101M21, 316M9 and 513J1 (43, 99 and 59 respectively) makes these conclusions highly reliable. From BAC 513J1 to 10A23, the percentage of BCG distal to the signals decreases progressively to almost 0. Figure 2d recapitulates these data on a curve, the slope of which directly reflects the relative level of fragility of the sequences along the region under study.
In order to confirm the limits of the site, we performed two-color FISH experiments with BAC 474E7 and 434E11 or 10A23. As expected, the two signals appear separated by the BCG observed at 6C1. We also verified that BCG occur frequently in the region delimited by BAC 316M9 and 513J1. Among 24 BCG observed within band 6C1, 10 separated the two probes and two split signals were seen for each BAC, five breaks were proximal and five were distal to both BAC ( Figure 1c ).
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c Number of metaphases where the BCG appear distal to the hybridization signal. mice, FISH experiments were performed on metaphase spreads of normal splenocytes of Swiss mice that were treated in vitro with AP (see Materials and methods). Metaphase spreads were hybridized with a painting probe specific to chromosome 6 and BAC 513J1. As expected, two normal chromosomes 6 were observed in each cell (Figure 1d1 ). However, we observed one cell with a reciprocal translocation, a breakpoint of which lies just proximal to the BAC probe (Figure 1d2 ). We scored fewer events than above because, in contrast to cells 531, metaphase spreads of normal splenocytes displaying BCG were infrequent, and the frequency of BCG per metaphase was also very low. This could result from differences in the genetic background of the two cell types. For example, a stringent G2/M checkpoint in primary splenocytes cells may prevent cells with broken chromosomes to enter mitosis. However, almost 40% (24 out of 66) of the BCG taking place on chromosome 6 were observed in the grid2 region, which indicates that a fragile region is also present in these cells. This conclusion is supported by the results of the two-color FISH experiments with probes 166G7 and 513J1 showing that 30% of the BCG occur between the two signals, or split one of them (Figure 1d3 ).
This fragile site is conserved in the human genome
The grid2/GRID2 genes belong to a region of synteny extending over a total of 7 Mb at mouse 6C1 and human 4q22 (Figures 2b and 4b) . In order to determine whether a fragile site also lies in the human genome, we performed preliminary experiments with a probe specific to band 4q22 on AP-treated lymphocytes of three healthy blood donors (Figure 3a) . Some 2.2% of the BCG scored were present within the FISH signals, which represents about 30 % of those occurring on chromosome 4 (average of the three donors), indicating that a CFS lies within that band. We mapped it precisely by studying metaphase spreads of one donor with 11 BAC surrounding GRID2 (Figure 4c ). The assignment of BAC 604B8 to 4q22 was verified by probing Rbanded metaphases (Figure 3b ). The location of BCG relative to the FISH signal of each BAC was determined as above (Figure 3c1-6) . The results are summarized in Table 2 and Figure 4e . More than 90% of the BCG were distal to the FISH signals of BAC 466G12 to 549C16, indicating that the fragile region is telomeric to these probes. For BAC 604B8, 254A24 and 9B6, BCG occurred proximal or distal to the FISH signals at relatively similar frequency, which defines the core of the fragile site. From BAC 9B6 to 145G20, the percentage of BCG distal to the FISH signals decreases progressively to almost 0 (Figure 4e ). Comparing the slope of the curve in Figures 4e and 2d discloses conserved distributions of the breaks along the regions of synteny. Two-color FISH experiments performed with probes 9B6 and 198E18 confirmed the presence of BCG in GRID2 (Figure 3c7 ) and definitely established that a CFS, named FRA4F, overlaps this region in the human genome.
Analysis of sequence features within the human locus
We compared the base composition of the two orthologous regions and found that the mouse and human loci exhibit, respectively, 62.4 and 63% of AT in the fragile site. The detail in AT composition of the human region is shown in Figure 4f . By analysing the repeat composition of the region with the repeat masker program, we found that both sequences display a high proportion of LINE (mostly LINE1) and a few SINE, a profile similar to the one found in mouse and human control regions with comparable AT-content (Smit, 1999) . Moreover, no significant differences were disclosed between the subregions of the sites and the sequences extending outside the sites (not shown). Thus, it is unlikely that the density and/or the type of repeats found in these orthologous CFS contribute efficiently to the fragility. We also studied the DNA flexibility along the 7-Mblong human fragile region and control sequences extending over 3.5 Mb on each side of the site, by using the FlexStab computer program (Mishmar et al., 1998) . A sequence is considered to be flexible when clusters of peaks (fluctuation of the twist angle higher than the mean þ 4.5 s.d.) appear per window of 350 kb, the maximum length of DNA that can be studied at once with the program. Figure 4f shows that the frequency of peaks is low in the 3.5-Mb-long control region centromeric to the site. Within the site, their frequency increases and culminates within GRID2 (more than 30 peaks per window). Outside the site towards the telomere, the frequency of peaks remains high, even though lower than inside the site. Sequencing of the orthologous region in the mouse genome is not finished yet, which prevented us to perform the same type of analysis.
Discussion
Spontaneous grid2 mutants appear at high frequencies in inbred mouse populations, which suggested that the grid2 gene lies in an unstable chromosomal region. In complete agreement with this hypothesis, we showed that 30-40% of the BCG induced by AP on chromosome 6, in cells of line 531 and in normal splenocytes from Swiss mice, occur within an about 11-Mb-long sequence containing the gene (Figures 1 and  2 ). Owing to its amino acid similarity with the family of kainate and aspartate receptors, the protein encoded by the grid2 gene is believed to be an ionotropic glutamate receptor, the expression of which appears restricted to purkinje cells in the cerebellum (Yuzaki, 2003) . Until now, no ligand has been identified for the d2 receptor and its function remains largely unknown. However, mutations in grid2 cause cerebellum ataxia. In total, 11 recessive mutations abolishing grid2 expression were analysed at the molecular level. Among them, nine result from deletions of one or more exons and one corresponds to the spontaneous integration of an exogenous DNA sequence (Figure 2b ) (Lalouette et al., 2001; Wang et al., 2003) . Interestingly, all the mutations lie in the part of grid2 that is especially prone to breakage (Figure 1c, Figure 2d ). This suggests that recurrent mutations in the grid2 gene result from the expression of Fra6C1 in germline cells.
We studied the fragility associated with human 4q22 in the lymphocytes of three healthy blood donors, and found that 30% of the BCG induced on chromosome 4 by AP-treatment occur within this band (Figures 3a, c  and 4c ). These BCG account for 1.9 to 2.4% of the total events scored. Human CFS described so far display important variations in length, from 200 kb for FRA7H (Mishmar et al., 1998) to 9 Mb for FRA9E (Callahan et al., 2003) . Detailed analysis along the 7 Mb of FRA4F disclosed 2 subregions where BCG occur at a relatively high frequency. They flank an about 2-Mb-long more stable sequence (Figure 4e ), a situation resembling the one disclosed at FRA9E, but contrasts with the relatively compact core region of most other CFS described so far. The grid2/GRID2 genes extend on more than a megabase while coding a few kb-long mRNA. Fra6C1/FRA4F share this property with at least three other cloned CFS, FRA3B (FHIT), FRA16D (WWOX) and FRA6E (PARKIN) (Krummel et al., 2000; Becker et al., 2002; Denison et al., 2003a) . This suggests that some features present in large genes lying in AT-rich regions, such as particular chromatin organization, favor chromosome instability.
Previous work on FRA7H suggested that regions of preferential BCG within CFS correlate with sequences enriched in peaks of enhanced flexibility (Mishmar et al., 1998) . In good agreement with this hypothesis, a high number of peaks of flexibility were found in all cloned CFS to date (Arlt et al., 2003) . Clusters of peaks of flexibility are also present in FRA4F, but their density does not completely account for the relative fragility of the different subregions of the site and its flanking regions. We also studied the AT-richness of this region by using the same 350 kb-window. As shown Figure 4f , the AT-content does not exactly parallel but is correlated to flexibility. This was expected since ATcontent is one of the parameter taken into account to calculate flexibility. Indeed, the 350-kb-long region exhibiting the highest number of flexibility peaks (more than 30) has also the highest AT-content (465%) and is located in GRID2 (Figure 4f ), a result in agreement with the analysis of the other AP-CFS.
The conservation of CFS among different species is still poorly documented. Only two human sites, FRA3B and FRA16D, have been compared at the molecular level to their mouse orthologs, Fra14A2 and Fra8E1 (Glover et al., 1998; Pekarsky et al., 1998; Krummel et al., 2002) . The relative organization of the genes and of the fragile regions was found well conserved in both cases. Here, the comparison of the about 7-Mb-long regions of synteny also discloses a good conservation of the location of the genes relative to the two subregions prone to BCG and of the large relatively stable region that separates them (Figures 2 and 4) .
Whether the mouse and human sites cloned here have been previously mapped by classical cytogenetic analysis is unclear. Furuya et al. (1989) described a CFS that accounts for 13.4% of the total BCG scored in human bone marrow cells of healthy persons at 4q21-25 (the most expressed in these cells). Recurrent BCG were also localized at 4q21 or 4q23 in other types of cells (Murano et al., 1989; Caporossi et al., 1995; Gericke et al., 1996; Simonic et al., 1997) . In the mouse genome, no CFS was described at 6C1, but one analysis localized a relatively weak site at 6B3, the band directly adjacent to 6C1 (Elder and Robinson, 1989) . Taking into account the low precision of G-banding mapping, the BCG observed in these studies may take place at the sites identified here at the molecular level.
Whether the 4q22 region also constitutes a hotspot of deletion in human germinal cells has not been extensively studied. However, a constitutive deletion of 8 cM at 4q21-22 has been reported once in an infant, which developed an hepatoblastoma (Terada et al., 2001) . Germline deletions involving 4q22 have also been reported in 11 patients presenting an overgrowth of the central nervous system (Nowaczyk et al., 1997) . Some of these deletions have a border in/near FRA4F and may result from its expression in germinal cells. Together with the properties of grid2 mutations, these observations suggest that recurrent mutations in germline cells may result from the location of target genes in CFS. This conclusion is actually supported by several lines of evidence. For example, mutant mice presenting the 'dominant white spotting' phenotype, which resembles human piebaldism, also appear at high frequency in inbred populations. These animals bear mutations in the kit gene. Some 30% of the mutations characterized at the molecular level are deletions or other chromosome rearrangements (MGD). We have shown that an AP-CFS also overlaps the kit gene (to be published). Interestingly, the gene responsible for human piebaldism, c-KIT, was assigned to a subregion of 4q12 within which lies the AP-CFS FRA4B . Together with the conclusions of a recent work on FRA6E (Denison et al., 2003a, b) , our results show that instability at CFS not only accounts for the high frequency of chromosome rearrangements involved in cancer progression but also for recurrent mutations in genes responsible for various inherited diseases. Conversely, the position of FRA11A relative to the boundaries of amplicons found in human cancers suggests that some RFS play a role in tumor progression (Perucca-Lostanlen et al., 1997) . Hence, depending on the nature of the genes embedded in a site, it may contribute to both germinal and somatic mutations, independent of its classification as rare or common.
In order to determine whether FRA4F activation triggers chromosome rearrangements found in cancers, we screened the literature searching for recurrent events involving 4q22. Deletions on the long arm of chromosome 4, complete or partial, have been reported in 30-70% of HCC tumors (Yeh et al., 1996; Nagai et al., 1997; Wong et al., 2000; Laurent-Puig et al., 2001) . Deregulation of the Wnt/Wingless pathway has been associated recently with the development of some HCC (Buendia, 2000) . This deregulation could be mediated either by b-catenin activation, which correlates with overexpression of three genes of the glutamine pathway (Glutamine Synthetase, Ornithine AminoTransferase, glutamate transporter GLT-1) or by Axin-1 inactivation (Legoix et al., 1999; Laurent-Puig et al., 2001; Cadoret et al., 2002) . Chromosomal instability and LOH on chromosome 1p, 4q, 16p, 16q have been correlated to axin-1 inactivation. At least in aflatoxin B1-induced HCC, LOH at 16q results from activation of FRA16D, but the target gene remains to be found (Yakicier et al., 2001) . In a recent work (Bluteau et al., 2002) , 36 primary liver tumors with partial deletions of 4q have been studied by high-density allelotyping, which identified three distinct regions of LOH. Among them, nine interstitial deletions map at 4q22. The minimal region common to these deletions extends over 15 Mb from A/ C-231 to D4S2986. Strikingly, FRA4F lies at the center of that region, which supports the hypothesis that, like FRA16D, this site is involved in liver carcinogenesis. Deletions in the same region were also found in cervical cancer (Mitra et al., 1994) . A gene involved in cellular senescence was also postulated to lie in this region in squamous cell carcinoma and in HeLa cells . However, none of the genes analysed so far were mutated in cancer cells, which indicates that the relevant one remains to be discovered (Bluteau et al., 2002; Bryce et al., 2002; Forsyth et al., 2002) . Nevertheless, taken together, these results suggest that FRA4F, like most other cloned CFS, contributes to the inactivation of a tumor suppressor gene.
Materials and methods
BAC clones and probes
The human/mouse BAC were chosen according to their position in the genome draft sequence assembly and from BLAST htgs (standard option) analysis, with GRID2/grid2 mRNA sequences. Human BAC were all chosen in the RPCI-11 library, and mouse BAC from the RPCI-23 library, except BAC CITB-513J1 previously described (De Jager et al., 1997) and BAC 316M9 a kind gift from A Lalouette. BAC were purchased from the BACPAC Resources web site (http:// www.chori.org/bacpac), their DNAs were prepared according to the recommendations of the supplier and verified by PCR. Mouse chromosome 6 and human 4q22 painting probes were obtained from Qbiogene, Illkirch, France.
Cell culture and fragile site induction
The fibroblastic cell line 531 was obtained from O Acuto and was routinely grown in DMEM containing 10% fetal calf serum (FCS) and penicillin/streptomycin (1/100). Splenocytes from Swiss mice were recovered and cultured as previously described (Elder and Robinson, 1989) . Human lymphocytes were obtained from three informed healthy peripheral blood donors, and cultured 72 h in RPMI medium supplemented with 10% FCS, and 30 mg/ml of PHA (BioSepra). Fragile sites were induced by treating the cells 18 h with AP (0.1-0.8 mg/ml), nocodazole (10 mM) was added 4-6 h before harvesting, and 2.5 mM of caffeine (Sigma) 1 h prior to nocodazole addition.
FISH and cytogenetic techniques
BAC labelling, chromosome preparations and FISH were performed as described (Toledo et al., 1992; Coquelle et al., 1997) with minor changes, that is, 200 ng of the probe was mixed with 1 mg of competitor Cot-1 DNA (human or mouse; Life Technologies). In some experiments, chromosomes were stained with DAPI and identified by computer-generated reverse-DAPI banding. GRID2 localization was performed on human metaphasic chromosomes prepared from human peripheral blood lymphocytes grown for the last 7 h before harvesting in the presence of BrdU (10 mg/ml, Sigma). Direct R-banding of 5-BrdU-substituted chromosomes was obtained as previously described (Lemieux et al., 1992) .
